Arbaclofen

A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis

Arbaclofen vs. Placebo in the Treatment of Children and Adolescents With ASD (ARBA)

Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion

Arbaclofen in Children and Adolescents With ASD

A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS

A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity

An Open Label Extension Study in Subjects With Fragile X Syndrome

Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome

Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome

Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders

Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders

An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders

An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome